Latest Market News

Savana Asset Management signals a strategic shift favoring US small caps amid easing Federal Reserve rates and cooling enthusiasm for mega-cap tech stocks. Kohl’s standout earnings further boost the fund’s outlook.

Larvotto Resources reports robust diamond drilling results at its Hillgrove project, confirming thick, high-grade gold-antimony mineralisation at Eleanora and Golden Gate. Exploration now shifts to promising new targets at Metz and Freehold.

Thor Energy has signed a term sheet with DISA Technologies to explore processing abandoned uranium waste dumps in Colorado, aiming to generate revenue without upfront costs using innovative HPSA technology.

Patriot Battery Metals has reached a significant milestone in the permitting process for its Shaakichiuwaanaan Lithium Project, with federal and provincial environmental assessments now aligned and progressing on schedule.

Compumedics has secured FDA clearance for its single-use Somfit®D device, effectively doubling its addressable U.S. home sleep testing market to an estimated US$240 million annually. This milestone positions the company to capture significant market share with a dual-platform EEG-based solution.

Green360 Technologies announces CEO Bojan Bogunovic's resignation effective October 31, with Executive Chairman Aaron Banks stepping in to lead daily operations during a pivotal growth phase.

Novo Resources has initiated its first reverse circulation drilling at the Sherlock Crossing gold-antimony prospect, while advancing exploration at its Wyloo polymetallic project and NSW gold assets, signaling a busy second half of 2025.

Metallium Ltd has appointed former U.S. Deputy Assistant Secretary of Defense Travis Langster to its U.S. advisory board, aiming to strengthen ties with government and industry for critical metals supply chain resilience.

Core Lithium has launched a $10 million Share Purchase Plan offering eligible shareholders the chance to buy new shares at the same price as a recent institutional placement, aiming to bolster working capital and support key project developments.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Iress Limited has appointed Andrew Russell as its new Group CEO, marking a strategic leadership shift following a major company transformation. Russell’s extensive fintech experience positions him to lead Iress into a product and client-focused future.

Control Bionics Limited has announced a 1-for-5 non-renounceable rights issue to raise up to $2.06 million, aiming to fund the commercial expansion of its NeuroStrip® device and operational growth. The offer is partially underwritten and open to eligible shareholders in Australia and New Zealand.